GlassScriptPhysician profile
Guozi Weng
NPI 1124790605
$2,957.81
in general payments reported to CMS, 2019-2025
17 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.32 · 2022: $561 · 2023: $898 · 2024: $1,007 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,328.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,080.31 | 2021-2025 | Vemlidy |
| Abbvie INC. | $873.30 | 2021-2024 | |
| Amgen INC. | $230.03 | 2022-2024 | Repatha, Otezla, Evenity |
| Amarin Pharma, INC. | $219.56 | 2022-2023 | |
| Pfizer INC. | $113.01 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.51 | 2023-2025 | Jardiance |
| Phathom Pharmaceuticals, INC. | $55.57 | 2023-2024 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $50.29 | 2022 | |
| Ibsa Pharma INC. | $43.88 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $40.84 | 2023-2024 | Breztri, Farxiga |
| Exact Sciences Corporation | $26.36 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $25.89 | 2025 | |
| Lilly USA, LLC | $23.84 | 2023 | Jardiance |
| Astellas Pharma US INC | $22.32 | 2024 | Veozah |
| Merck Sharp & Dohme LLC | $20.90 | 2025 | Lagevrio |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $19.45 | 2025 | |
| Horizon Therapeutics Plc | $18.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guozi Weng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.